Rare
lephants
Screener
Toggle theme
SELLAS Life Sciences Group, Inc.
SLS
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Assets & Liabilities
Equity & Debt
Asset & Liabilities Breakdown
Balance Sheet
›
Assets & Liabilities
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Assets & Liabilities
Chart
Table
Total Liabilities
Total Assets
Cash on Hand
Fiscal Year
Total Liabilities
Total Assets
Cash on Hand
FY2025
$7.5M
$78.3M
$71.8M
Download CSV
